Xinyu Liu

Xinyu Liu

Auto-generated profile, based on publicly available information

Xinyu Liu

The Third Department of Breast Cancer Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Tianjin China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2022 in Disease Markers
Verified
Journal Article
Open access
PDF file
SWShunan Wang
Shunan Wang
XLXinyu Liu
Xinyu Liu
MYMeng Yang
Meng Yang
DYDongqi Yuan
Dongqi Yuan
Kui YeKui Ye
Kui Ye
XWXinchao Wang
Xinchao Wang
Background. A tumor occurs because of abnormal cell multiplication caused by many variables like a significant disturbance in the regulation of cell growth and the instability of chromosome mitosis. Budding uninhibited by benzimidazoles 1 (BUB1), BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B), and budding uninhibited by benzimidazoles 3 (BUB3) are key regulators of mitosis, and their abnormal expression is highly correlated with breast cancer (BrCa), sarcoma, hepatic carcinoma, and other malignant tumors. However, the occurrence of BUBs (BUB1, BUB1B, and BUB3) and the development of BrCa have not been systematically explained. Methods. Find out the target gene by looking up literature on PubMed and CNKI. Using the R software, TCGA, GEO, Kaplan-Meier Plotter, TIMER, and other databases, we studied the level of transcription, genetic changes, and physiological functions of BUBs in BrCa patients and their relationship with the origin, development, prognosis, immunity, and drug resistance of BrCa patients. Findings. We found that the high expression level of BUBs in BrCa tissues proposed a poor prognosis. The multivariate Cox regression analysis suggested that BUB1B and BUB3 might be independent prognostic factors of BrCa. In addition, the Metascape functional enrichment analysis showed that BUBs may be involved in the composition of the spindle, chromosome, and other structures and play a role in mitosis, sister chromatid separation, and other processes. Pathway enrichment suggests that BUBs may affect the cell cycle and lead to abnormal proliferation. Meanwhile, we also found that BUB3 can negatively regulate B lymphocytes, and BUB1 and BUB1B inhibit immune responses by promoting the secretion level of checkpoint molecules of the immune system, leading to immune escape of tumor cells. Conclusion. We speculate that BUB1, BUB1B, and BUB3 may be therapeutic targets for BrCa patients and also provide new therapeutic strategies for BrCa treatment.

26 August 2025 in World Journal of Surgery
Verified
Journal Article
Closed access
XLXinyu Liu
Xinyu Liu
YLYan Liu
Yan Liu
TMTao Ma
Tao Ma
SZShichao Zhang
Shichao Zhang
LLLei Liu
Lei Liu
JZJin Zhang
Jin Zhang